AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- NEW ORLEANS -- Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut relative risk...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
(MedPage Today) -- NEW ORLEANS -- A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO's landmark report on ultrasound-facilitated, catheter-directed thrombolysis (CDT). In this hard-to-treat...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...
(MedPage Today) -- Every week in the pediatric emergency department, I watch the consequences of adolescent substance use arrive through our doors. Overdoses. Acute intoxication. Psychiatric crises triggered by substances that started as experimentation...